NCT07500298
- Conditions
- Bevacizimab, Colonic Diseases, Colorectal Neoplasms, +15 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Phase 1
Explore clinical trials studying Phase 1. Study availability and eligibility vary by location and protocol.
19 public trials
3 recruiting studies
Phase 1 trial results
NCT07072234
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT06660420
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07579208
- Conditions
- Astrocytoma, Chimera Antigen Receptor (CAR), EGFRvIII, +14 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Completed
A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate
NCT03488719
- Conditions
- Phase 1
- Locations
-
- Parexel International GmbH; Early Phase Clinical Unit Berlin Berlin, Germany
NCT05068947
- Conditions
- Phase 1
- Locations
-
- Clinical Pharmacology of Miami Hialeah, Florida, United States
NCT04327089
- Conditions
- Phase 1
- Locations
-
- Eurofins Optimed Gières, France
Completed
Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets
NCT03740217
- Conditions
- Phase 1
- Locations
-
- Eurofins Optimed Gières, France
NCT03983876
- Conditions
- Phase 1
- Locations
-
- Christchurch Clinical Studies Trust Limited Christchurch, Chistchurch, New Zealand
- Auckland Clinical Studies Auckland, New Zealand
NCT04014257
- Conditions
- Phase 1, Solid Tumor, Adult
- Locations
-
- National Cancer Center Goyang-si, Gyeonggi-do, South Korea
- CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
- Seoul National University Hospital Seoul, South Korea
- Severance Hospital Seoul, South Korea